P/F BankNordik (BNORDIK-CSE.CO)
DKK 154.5
(0.65%)
DKK 154.5
(0.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 311.53 Million | 279.88 Million | 3.87 Billion | 336.29 Million | 278.54 Million | 149.37 Million |
| Net Income | 300.57 Million | 206.57 Million | 339.56 Million | 206.44 Million | 259.77 Million | 323.29 Million |
| Depreciation & Amortization | 7.42 Million | 3.94 Million | 7.02 Million | 17.75 Million | 14.92 Million | -43.8 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 30.55 Million | 194.79 Million | 3.61 Billion | 165.71 Million | 148.09 Million | 36.1 Million |
| Other non-cash items | -27.02 Million | -125.43 Million | -84.11 Million | -53.62 Million | -144.24 Million | -166.22 Million |
| Investing Cash Flow | -500 Million | 4.76 Million | -3.3 Billion | 5.3 Million | 16.71 Million | 131.53 Million |
| Investments in PPE | -7 Million | -1.72 Million | -4.91 Million | -7.28 Million | -14.18 Million | -19.8 Million |
| Acquisitions | 24.86 Million | 19 Thousand | -3.3 Billion | 30 Thousand | 16.92 Million | 139.94 Million |
| Investment purchases | - | -47.97 Million | -2.64 Billion | -1.11 Billion | -1.04 Billion | -356.01 Million |
| Sales/Maturities of investments | 260.62 Million | 227.63 Million | 2.64 Billion | 1.11 Billion | 1.02 Billion | - |
| Other Investing Activities | -778.48 Million | -173.18 Million | 8.63 Million | 12.58 Million | 30.9 Million | 151.33 Million |
| Financing Cash Flow | 411.57 Million | -188.95 Million | -284.77 Million | -17.84 Million | -159.85 Million | -53.75 Million |
| Debt repayment | -299.48 Million | -227.32 Million | -125 Million | -26.63 Million | -94.72 Million | -61.88 Million |
| Dividends payments | -249.28 Million | -384.9 Million | -496.48 Million | -6.75 Million | -66.78 Million | -40 Million |
| Common Stock Repurchased | - | - | -952 Thousand | -591 Thousand | -7.05 Million | -14.93 Million |
| Common Stock Issuance | - | - | 337.66 Million | 33.38 Million | 94.72 Million | 7000.00 |
| Other Financing Activities | 960.34 Million | 424.36 Million | 1.51 Million | -17.25 Million | -82.8 Million | 1.17 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 30.55 Million | 194.79 Million | 3.61 Billion | 165.71 Million | 148.09 Million | -763.65 Million |
| Cash at beginning of period | 1.83 Billion | 1.73 Billion | 1.45 Billion | 1.12 Billion | 994.47 Million | 767.32 Million |
| Cash at end of period | 2.05 Billion | 1.83 Billion | 1.73 Billion | 1.45 Billion | 1.12 Billion | 994.47 Million |
| Capital Expenditure | -7 Million | -1.72 Million | -4.91 Million | -7.28 Million | -14.18 Million | -19.8 Million |
| Effect of forex changes on cash | - | - | - | - | 1000.00 | - |
| Net cash flow / Change in cash | 223.1 Million | 95.69 Million | 283.33 Million | 323.75 Million | 135.41 Million | 227.15 Million |
| Free Cash Flow | 304.52 Million | 278.15 Million | 3.86 Billion | 329 Million | 264.36 Million | 129.56 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 85.26 Million | 70.08 Million | 108.79 Million | 300.57 Million | 150.82 Million | 53.98 Million |
| Depreciation & Amortization | 2.19 Million | 2.37 Million | 1.92 Million | 7.42 Million | 1.95 Million | 1.98 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -132.36 Million | 358.63 Million | -20.95 Million | 30.55 Million | -190.93 Million | 59.98 Million |
| Other non-cash items | 18.15 Million | -3.18 Million | -69.39 Million | -27.02 Million | -46.85 Million | 20.37 Million |
| Investing Cash Flow | -21.28 Million | -6.97 Million | 15.83 Million | -500 Million | 3.56 Million | -5.4 Million |
| Investments in PPE | -1.33 Million | -6.97 Million | -3.83 Million | -7 Million | -1.44 Million | -432 Thousand |
| Acquisitions | - | - | 19.66 Million | 24.86 Million | - | -209.72 Million |
| Investment purchases | 14.94 Million | -14.94 Million | -103.52 Million | - | - | 31.12 Million |
| Sales/Maturities of investments | 69.29 Million | 10.58 Million | 83.85 Million | 260.62 Million | -1.82 Million | 178.59 Million |
| Other Investing Activities | 11.99 Million | -3.99 Million | 19.66 Million | -778.48 Million | 6.83 Million | -4.97 Million |
| Financing Cash Flow | 168.56 Million | -95.42 Million | 402.94 Million | 411.57 Million | -8.02 Million | -250.55 Million |
| Debt repayment | -4.35 Million | -30.91 Million | -286.96 Million | -299.48 Million | -1.27 Million | -238.4 Million |
| Dividends payments | - | -79.78 Million | - | -249.28 Million | -6.75 Million | -249.28 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -14.28 Million | -14.06 Million | 689.91 Million | 960.34 Million | 173.63 Million | 237.13 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -142.38 Million | 61.72 Million | -20.95 Million | 30.55 Million | -190.93 Million | 59.98 Million |
| Cash at beginning of period | 2.4 Billion | 2.05 Billion | 1.61 Billion | 1.83 Billion | 1.7 Billion | 1.82 Billion |
| Cash at end of period | 2.52 Billion | 2.4 Billion | 2.05 Billion | 2.05 Billion | 1.61 Billion | 1.7 Billion |
| Capital Expenditure | -1.33 Million | -6.97 Million | -3.83 Million | -7 Million | -1.44 Million | -432 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 116.12 Million | 348.93 Million | 439.14 Million | 223.1 Million | -89.47 Million | -119.64 Million |
| Free Cash Flow | -32.48 Million | 444.35 Million | 16.52 Million | 304.52 Million | -86.46 Million | 135.89 Million |
MLEDU
688595
CCSI
CABB
DGL
MEDVF